Methotrexate combined with omalizumab for difficult to treat urticaria: a further step-up treatment?

P. Garbayo-Salmons (Lead / Corresponding author), S. Butt, Robert S. Dawe

Research output: Contribution to journalLetterpeer-review

20 Downloads (Pure)

Abstract

Classically, chronic urticaria has been treated following a stepwise approach where Omalizumab and other immunosuppressants occupy the last step. Omalizumab and Methotrexate have both been used separately for the treatment of urticaria1,2 . We believe combination treatment with both agents is a valuable alternative for refractory chronic urticaria and other related diseases such as urticarial vasculitis. Here we report on two patients who responded to the combination treatment.

Original languageEnglish
Pages (from-to)350-351
Number of pages2
JournalClinical and Experimental Dermatology
Volume46
Issue number2
Early online date29 Jun 2020
DOIs
Publication statusPublished - Mar 2021

Fingerprint

Dive into the research topics of 'Methotrexate combined with omalizumab for difficult to treat urticaria: a further step-up treatment?'. Together they form a unique fingerprint.

Cite this